Accurate detection of carcinoma cells by use of a cell microarray chip

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Yamamura, Shohei ^a   Yatsushiro, Shouki ^a   Yamaguchi, Yuka ^a   Abe, Kaori ^a   Shinohara, Yasuo ^b   Tamiya, Eiichi ^c   Baba, Yoshinobu ^a,d   Kataoka, Masatoshi ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN ANTIBODY; MONOCLONAL ANTIBODY; POLYSTYRENE; CELL ADHESION MOLECULE; KERATIN; POLYSTYRENE DERIVATIVE; TUMOR ANTIGEN; TUMOR ASSOCIATED ANTIGEN GA733; TUMOR-ASSOCIATED ANTIGEN GA733;

ACCURACY; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL MICROARRAY CHIP; CONTROLLED STUDY; EQUIPMENT DESIGN; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; LABORATORY DEVICE; LEUKOCYTE; LUNG CARCINOMA; LYMPHOBLASTOID CELL; BIOSYNTHESIS; CARCINOMA; CELL SEPARATION; CHEMISTRY; CYTOLOGY; DNA MICROARRAY; FLUORESCENCE MICROSCOPY; METABOLISM; METASTASIS; METHODOLOGY; NEOPLASM; REPRODUCIBILITY; T LYMPHOCYTE; TUMOR CELL LINE; TUMOR EMBOLISM;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CARCINOMA; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL SEPARATION; HUMANS; KERATINS; LEUKOCYTES; MICROSCOPY, FLUORESCENCE; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYSTYRENES; REPRODUCIBILITY OF RESULTS; T-LYMPHOCYTES;

EID: 84857703045     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032370     Document Type: Article

References (17)

1. Paterlini-Brechot P, Benali NL, (2007) Circulating tumor cells (CTC) detection: clinical and future directions. Cancer Lett 253: 180-204.
2. Alunni-Fabbroni M, Sandri MT, (2010) Circulating tumor cells in clinical practice: Methods of detection and possible characterization. Methods 50: 289-297.
3. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, et al. (2007) Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450: 1235-1239.
4. Isaiah JF, (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nature Reviews Cancer 3: 453-458.
5. Mocellin S, Keilholz U, Rossi CR, Nitti D, (2006) Circulating tumor cells: the 'leukemic phase' of solid cancers. Trends Mol Med 12: 130-139.
6. Di Carlo D, Lee LP, (2006) Dynamic single-cell analysis for quantitative biology. Anal Chem 78: 7918-7925.
7. Yamamura S, Kishi H, Tokimitsu Y, Kondo S, Honda R, et al. (2005) Single-cell microarray chip for analyzing cellular responses. Anal Chem 77: 8050-8056.
8. Yatsushiro S, Yamamura S, Yamaguchi Y, Shinohara Y, Tamiya E, et al. (2010) Rapid and highly sensitive detection of malaria-infected erythrocytes using a cell microarray chip. PLoS One 5: e13179.
9. Den Toonder J, (2011) Circulating tumor cells: the Grand Challenge. Lab Chip 11: 375-377.
10. Mostert B, Kraan J, Bolt-de Vries J, van der Spoel P, Sieuwert AM, et al. (2011) Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146. Breast Cancer Res Treat 127: 33-41.
11. Sieuwerts AM, Kraan J, Bolt J, van der Spoel P, Elstrodt F, et al. (2009) Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst 101: 61-66.
12. Punnoose EA, Atwal SK, Spoerke JM, Savage H, Pandita A, et al. (2010) Molecular biomarker analyses using circulating tumor cells. PLoS One 5: e12517.
13. Deng G, Herrler M, Burgess D, Manna E, Krag D, Burke JF, (2008) Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic cancer patients. Breast Cancer Res 10: R69.
14. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752.
15. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98: 10869-10874.
16. Masuda K, Takano A, Oshita H, Akiyama H, Tsuchiya E, et al. (2011) Chondrolectin is a novel diagnostic biomarker and a therapeutic target for lung cancer. Clin Cancer Res 17: 1-11.
17. Park Y, Kitahara T, Urita T, Yoshida Y, Kato R, (2011) Expected clinical applications of circulating tumor cells in breast cancer. World J Clin Oncol 2: 303-310.